Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix™) in adults

Travel Medicine and Infectious Disease

Volumn 5, Issue 3, 2007, Pages 171-175

  Van Herck, K ^a   Leroux Roels, G ^b   Van Damme, P ^a   Srinivasa, K ^c   Hoet, B ^d  

^a WHO Collaborating Centre for Prevention and Control of Viral Hepatitis   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GLAXOSMITHKLINE   (United States)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Duration; Follow up study; Long term persistence; Protection; Vaccine induced antibodies

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; TRAVEL; TREATMENT OUTCOME; VACCINATION; VACCINES, COMBINED;

EID: 34247131249     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2006.07.003     Document Type: Article

References (18)

1. Spira A.M. A review of combined hepatitis A and hepatitis B vaccination for travellers. Clin Therapeut 25 (2003) 2337-2351
2. Van Damme P., Matheï C., Thoelen S., Meheus A., Safary A., and André F.E. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 44 (1994) 446-451
3. Davis J.P. Experience with hepatitis A and B vaccines. Am J Med 118 (2003) 75-155
4. Iwarson S. What type of travellers would benefit from combined vaccination against hepatitis A and B?. J Trav Med 5 (1998) 80-83
5. Thoelen S., Van Damme P., Leentvaar-Kuypers A., Leroux-Roels G., Bruguera M., Frei P.C., et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine 17 (1999) 1657-1662
6. Murdoch D.L., Goa K., and Figgitt D.P. Combined hepatitis A and B vaccines. A review of their immunogenicity and tolerability. Drugs 23 (2003) 2625-2649
7. Van Damme P., and Van Herck K. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine. Expert Rev Vaccines 3 (2004) 249-267
8. Van Damme P., Leroux-Roels G., Law B., Diaz-Mitoma F., Desombere I., Collard F., et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 65 (2001) 6-13
9. Banatvala J., Kane M., Da Villa G., Esteban R., Franco E., Goudeau A., et al. Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 355 9203 (2000) 561-565
10. Van Damme P., Banatvala J., Fay O., Iwarson S., McMahon B., Van Herck K., et al. Hepatitis A booster vaccination: is there a need?. Lancet 362 9389 (2003) 1065-1071
11. Kallinowski B., Knoll A., Lindner E., Saenger R., Stremmel W., Vollmar J., et al. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary vaccination course?. Vaccine 19 (2001) 16-22
12. Bauer T., and Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 24 (2006) 572-577
13. West D.J., and Calandra G.B. Vaccine induced memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 (1996) 1019-1027
14. Van Herck K., Van Damme P., Thoelen S., and Meheus A. Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast derived hepatitis B vaccine: 8 year results. Vaccine 16 (1998) 1933-1935
15. Van Herck K., and Van Damme P. Inactivated hepatitis A vaccine induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 63 (2001) 1-7
16. Van Herck K., Van Damme P., Lievens M., and Stoffel M. Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course. J Med Virol 72 (2004) 194-196
17. Bovier P.A., Bock J., Loutan L., Farinelli T., Glueck R., and Herzog C. Long-term immunogenicity of an inactivated virosome hepatitis A vaccine. J Med Virol 68 (2004) 489-493
18. Van Herck K., and Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 63 1 (2001) 1-7